David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
CALL
Ambarella
AMBA
$3.1B
| $251K | ﹤0.01% |
+5,800
| New | +$229K |
|
|
CUK
3252
DELISTED
Carnival PLC
CUK
| $250K | ﹤0.01% |
5,018
-140,477
| -97% | -$7.68M |
|
3253
German American Bancorp
GABC
$1.87B
| $250K | ﹤0.01% |
+8,490
| New | +$256K |
|
|
MIXT
3254
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $250K | ﹤0.01% |
+14,986
| New | +$257K |
|
3255
Alamo Group
ALG
$1.97B
| $249K | ﹤0.01% |
+2,493
| New | +$225K |
|
3256
CALL
ONE Gas
OGS
$5.05B
| $249K | ﹤0.01% |
+2,800
| New | +$235K |
|
|
ACGN
3257
DELISTED
Aceragen Inc
ACGN
| $249K | ﹤0.01% |
5,759
+2,586
| +82% | +$125K |
|
|
SLAI
3258
DELISTED
SOLAI Ltd ADS
SLAI
| $247K | ﹤0.01% |
253
-186
| -42% | -$177K |
|
3259
PUT
Ollie's Bargain Outlet
OLLI
$4.51B
| $247K | ﹤0.01% |
+2,900
| New | +$234K |
|
|
WPRT
3260
Westport Fuel Systems
WPRT
$35M
| $247K | ﹤0.01% |
+15,932
| New | +$233K |
|
3261
PUT
Beazer Homes USA
BZH
$885M
| $246K | ﹤0.01% |
21,400
-25,500
| -54% | -$305K |
|
3262
Cleveland-Cliffs
CLF
$6.57B
| $246K | ﹤0.01% |
24,669
-3,360,695
| -99% | -$33.6M |
|
3263
Rafael Holdings
RFL
$116M
| $246K | ﹤0.01% |
19,752
-100,229
| -84% | -$1.44M |
|
|
PVLA
3264
Palvella Therapeutics
PVLA
$2.14B
| $246K | ﹤0.01% |
917
+293
| +47% | +$69.6K |
|
3265
PUT
AptarGroup
ATR
$8.57B
| $245K | ﹤0.01% |
2,300
| – | – |
|
3266
PUT
The Greenbrier Companies
GBX
$1.43B
| $245K | ﹤0.01% |
+7,600
| New | +$303K |
|
3267
CALL
Applied Optoelectronics
AAOI
$9.61B
| $244K | ﹤0.01% |
+20,000
| New | +$302K |
|
3268
Xcel Energy
XEL
$48.2B
| $244K | ﹤0.01% |
4,342
-102,172
| -96% | -$5.43M |
|
3269
Aaon
AAON
$6.28B
| $243K | ﹤0.01% |
7,883
-33,520
| -81% | -$880K |
|
3270
Gorman-Rupp
GRC
$2.03B
| $242K | ﹤0.01% |
+7,138
| New | +$241K |
|
3271
Penske Automotive Group
PAG
$14.4B
| $242K | ﹤0.01% |
5,425
-16,097
| -75% | -$713K |
|
|
USX
3272
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $242K | ﹤0.01% |
36,675
+7,312
| +25% | +$56.8K |
|
|
GRA
3273
CALL
DELISTED
W.R. Grace & Co.
GRA
| $242K | ﹤0.01% |
+3,100
| New | +$228K |
|
|
BCPC
3274
CALL
Balchem Corp
BCPC
$5.72B
| $241K | ﹤0.01% |
2,600
| – | – |
|
3275
CALL
Equity Lifestyle Properties
ELS
$12.7B
| $240K | ﹤0.01% |
+4,200
| New | +$225K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.